Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Hybridoma ; 10(1): 95-102, 1991 Feb.
Article in English | MEDLINE | ID: mdl-2032737

ABSTRACT

ras genes have been shown to become oncogenes by single point mutations which result in amino acid substitutions that affect either their GTPase activity (positions 12, 13, 59, 61) or their affinity for GTP and GDP. Ras oncogenes and their corresponding proteins have been described in a variety of human cancers as well as in animal tumors induced by physical and chemical carcinogens. One of these animal tumor systems involves the induction of mammary carcinomas in rats by a single dose of N-nitroso-N-methylurea (NMU), a methylating carcinogen. These NMU-induced mammary carcinomas contain transforming H-ras genes activated by G----A transitions in the second nucleotide of their 12th codon, presumably a consequence of the pre-mutagenic lesions induced by NMU. These G----A mutations result in the replacement of the normal glycine in the 12th position of the ras p21 protein by a glutamic acid residue. In this study, we report the generation of monoclonal antibodies (Mab) reactive with oncogenic ras p21 proteins containing glutamic acid at position 12 (p21 Glu-12). Mab designated E184 specifically recognized activated ras p21 Glu-12 proteins but not normal p21 (Gly-12) or p21 proteins activated by other position 12 substitutions including arginine, aspartic acid, cysteine, valine or serine residues. Western blot analysis of NMU-induced mammary carcinomas demonstrated that Mab E184 recognized p21 proteins expressed in these rat tumors but not p21 present in normal tissues nor in other carcinogen-induced tumors known to carry H-ras oncogenes activated by mutations at position 61.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Antibodies, Monoclonal , Mammary Neoplasms, Experimental/immunology , Oncogene Protein p21(ras)/immunology , Animals , Antibodies, Monoclonal/biosynthesis , Antibodies, Neoplasm/biosynthesis , Antibody Specificity , Cell Line, Transformed , Female , Hybridomas/immunology , Mammary Neoplasms, Experimental/chemically induced , Methylnitrosourea , Mice , Rats
2.
Hybridoma ; 9(6): 573-87, 1990 Dec.
Article in English | MEDLINE | ID: mdl-2076896

ABSTRACT

Monoclonal antibodies (MAb) Ras 10 and Ras 11 were raised to an activated human Harvey-ras p21 and shown to react with recombinant p21 as well as p21 derived from human and rodent cells. Characterization studies by ELISA, immunoprecipitation and Western blot procedures demonstrated that MAb Ras 10 (IgG2a) and Ras 11 (IgG2b) react with normal p21, activated p21, and p21 from each of the Harvey, Kirsten and N-ras families. Studies illustrated that MAb Ras 10 and Ras 11 can also be used in flow cytometry and immunohistochemistry to specifically detect cellular p21. ELISA, immunoprecipitation and Western blot studies comparing rat anti-p21 MAb Y13-259 with Ras 10 and Ras 11 demonstrated that Ras 10 and Ras 11 had a greater sensitivity for ras protein detection than Y13-259. Collectively, these studies illustrate that MAb Ras 10 and Ras 11 can be applied to a variety of assay formats to detect ras proteins and, therefore, may be valuable tools in detecting and measuring of ras protein expression in normal, neoplastic and pre-neoplastic cells.


Subject(s)
Antibodies, Monoclonal , Oncogene Protein p21(ras)/immunology , Animals , Antibodies, Monoclonal/biosynthesis , Antibody Specificity , Flow Cytometry , Humans , Hybridomas/immunology , Immunohistochemistry , Mice , Oncogene Protein p21(ras)/isolation & purification , Oncogene Protein p21(ras)/metabolism , Precipitin Tests
3.
Oncogene ; 5(8): 1173-8, 1990 Aug.
Article in English | MEDLINE | ID: mdl-2202949

ABSTRACT

The ras proto-oncogenes encode membrane bound proteins (p21) which are structurally distinct from the proteins encoded by the activated transforming ras genes. These activated ras genes have been identified in various human tumors as well as their preneoplastic lesions such as colorectal tumors (20-40%), pancreatic carcinomas (95%), lung carcinomas (20-30%), myelodysplasia (40%) and acute myeloid leukemia (30%). The activation of ras p21 is due to amino acid substitutions at positions 12, 13 or 61 of the p21 protein. This report describes two monoclonal antibodies designated D129 and D146 raised against a synthetic peptide corresponding to amino acids 5-16 of ras p21 activated by the substitution of aspartic acid for glycine at position 13. D129 and D146 react specifically with the peptide with the aspartic acid substitution at position 13, but not with the peptide with valine at position 13 or the peptide containing the normal glycine at position 13. Western blot analysis demonstrates that D129 and D146 react specifically with p21 extracted from transformed NIH3T3 fibroblast lines containing aspartic acid at position 13. These studies also demonstrate that D146 is able to detect the activated p21 with aspartic acid at position 13 that is shed into the culture media. Studies demonstrate that MAb D146 specifically immunoprecipitates the cellular p21 with aspartic acid at position 13 from transformed NIH3T3 cells, whereas D129 cannot immunoprecipitate the activated p21. Using a sandwich ELISA format, D146 is able to detect the p21 with position 13 aspartic acid from cell extracts and culture fluids. The ability of D146 to function in the ELISA format raises the possibility that this assay maybe a quick and effective way of determining the presence of activated p21 with aspartic acid at position 13 in human fluids and tissues.


Subject(s)
Antibodies, Monoclonal , Gene Expression Regulation, Neoplastic , Proto-Oncogene Proteins/analysis , Animals , Antibodies, Monoclonal/immunology , Aspartic Acid , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mutation , Precipitin Tests , Proto-Oncogene Proteins/immunology , Proto-Oncogene Proteins p21(ras)
4.
Oncogene ; 4(5): 543-8, 1989 May.
Article in English | MEDLINE | ID: mdl-2566965

ABSTRACT

A series of monoclonal antibodies specific for the extracellular domain of the human neu gene product (p185) have been produced. The generation of these monoclonal antibodies, and their biochemical and immunological characterization is described. The immunization protocol utilized a series of injections of NIH3T3 cells, cyclophosphamide, and a neu transfected NIH3T3 cell line (designated 18-3-7) which expressed the full length human neu-encoded protein. This immunization regimen induced an immune response to the extracellular portion of p185 on the 18-3-7 cells. A panel of ten hybridomas were identified which secreted monoclonal antibodies with a variety of epitope specificities, and reacted with p185 in a number of different experimental formats. As the neu gene product has been associated with human breast cancers, a series of monoclonal antibodies such as these could prove useful in the diagnosis, prognosis and/or treatment of these human malignancies.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Proto-Oncogene Proteins/immunology , Animals , Antibodies, Monoclonal/immunology , Antibody Specificity , Blotting, Western , Cell Line, Transformed , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Fluorescent Antibody Technique , Humans , Hybridomas/immunology , Mice , Mice, Inbred BALB C , Oncogenes , Precipitin Tests , Proto-Oncogene Proteins/genetics , Receptor, ErbB-2
5.
Cancer Res ; 46(10): 4953-9, 1986 Oct.
Article in English | MEDLINE | ID: mdl-3756856

ABSTRACT

We have developed two monoclonal antibodies, designated 152 E12 D7 and 153 C7 A6, which have reactivity with cell surface antigens expressed on the B16 mouse melanoma. These monoclonal antibodies are produced by hybridomas resulting from the fusion of splenocytes taken from C57BL/6 mice bearing the B16-F10 tumor. The monoclonal antibodies are of the immunoglobulin M class and have been shown to react with three variants of the B16 and another mouse melanoma but no normal murine tissues. Exposure of B16 melanoma cells to a concanavalin A stimulated spleen cell mixed lymphokine preparation (LK) and to dimethyl sulfoxide (DMSO) enhanced the expression of the cell surface antigens recognized by these monoclonal antibodies. The cultures stimulated with LK or DMSO contained a greater proportion of cells expressing the antigens recognized by monoclonal antibodies 152 E12 D7 and 153 C7 A6 than did unstimulated controls. In addition to increasing the proportion of antigen-positive cells, the antigen expression per cell, as measured by fluorescence intensity, was substantially increased following exposure to LK and DMSO. The effects of treatment with LK or DMSO were apparent after 24 h exposure but did not persist after the agent was removed from the cultures, suggesting that the enhancement of antigen expression was a transient event rather than a permanent differentiation of the melanoma cells.


Subject(s)
Antigens, Neoplasm/analysis , Antigens, Surface/analysis , Dimethyl Sulfoxide/pharmacology , Lymphokines/pharmacology , Melanoma/immunology , Neoplasm Proteins/analysis , Animals , Antibodies, Monoclonal/immunology , Cell Line , Fluorescence , Male , Melanoma-Specific Antigens , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Neoplasm Proteins/biosynthesis
6.
Environ Res ; 41(1): 351-6, 1986 Oct.
Article in English | MEDLINE | ID: mdl-3093218

ABSTRACT

The effect of sulphur dioxide on the clearance of Listeria monocytogenes from normal and emphysematous hamsters was assessed by measuring the number of colony forming units recovered from whole lung homogenates. Continuous exposure to SO2 after intratracheal instillation of Listeria significantly altered the clearance of viable bacteria from the lungs of emphysematous but not normal hamsters. Preexposure of hamsters to SO2 for 2 weeks prior to respiratory infection had similar effects. The emphysematous hamsters exposed to SO2 had a lower average number of Listeria in the lungs after the first week of infection than control groups. This effect appears to result from the combined influence of the SO2, the Listeria infection, and the emphysematous condition within the lungs.


Subject(s)
Listeriosis/immunology , Lung Diseases/immunology , Lung/immunology , Pulmonary Emphysema/immunology , Sulfur Dioxide/pharmacology , Animals , Cricetinae , Listeria monocytogenes/immunology , Lung/microbiology , Macrophages/drug effects , Male , Mesocricetus , Phagocytosis/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...